Drugs / PRAX-114
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 23 trials | ||||||
| Phase 2 | NCT05387642 | Apr → Jun 2022 | essential tremor | Praxis Precision Medicines | Withdrawn | No outcome recorded |
| Phase 2 | NCT05260541 | Jan → Aug 2022 | post-traumatic stress disorder | Praxis Precision Medicines | Terminated | No outcome recorded |
| Phase 2 | NCT04969510 | Jun 2021 → Jul 2022 | major depressive disorder | Praxis Precision Medicines | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT04832425 | Mar 2021 → May 2022 | major depressive disorder | Praxis Precision Medicines | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRAX-114 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04969510 ↗ |
| Route | Oral | “Once daily oral treatment” NCT04969510 ↗ |